Howard Soule is the Chief Science Officer of the Prostate Cancer Foundation. He coordinates global academic, government and biopharmaceutical-sector research and is responsible for the implementation of PCF's global research strategies.  He is also a member of the Department of Defense Prostate Cancer Research Program Integration Panel. Dr. Soule has been with the Foundation for 20 years. Prior to joining PCF in 1997, Dr. Soule was a senior R&D executive for nine years at Corvas International, Inc., a public biotechnology company. He was responsible for the discovery and development of innovative products for the treatment of life-threatening cardiovascular diseases. Dr. Soule has considerable experience in medical diagnostic and device industries as well. Dr. Soule received a PhD from Baylor College of Medicine in Virology and Epidemiology and was a Post-Doctoral Fellow in Immunology and Vascular Biology at the Scripps Research Institute.